Using a new urinalysis system to reduce unnecessary antibiotic use for suspected UTIs
The Application of a Novel Urinalysis System (UF-5000) for Reducing Unnecessary Antibiotic Use in Clinical Suspected UTI Patients
This study is testing a new urine test to see if it can help doctors better identify urinary tract infections and reduce the unnecessary use of antibiotics in adults with lower urinary tract symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Trial ID | NCT06918769 on ClinicalTrials.gov |
What this trial studies
This study aims to implement a novel urine sediment analyzer, the UF-5000, to improve the diagnosis of urinary tract infections (UTIs) and reduce the unnecessary prescription of antibiotics. By providing rapid identification of potential bacteria in urine samples, the UF-5000 can help differentiate between actual UTIs and other conditions with similar symptoms. This approach seeks to address the growing problem of antibiotic resistance in Hong Kong, which has been exacerbated by empirical antibiotic treatments. The study will involve adult patients suspected of having lower urinary tract symptoms in an outpatient setting.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients who present with symptoms suggestive of lower urinary tract infections in an outpatient clinic.
Not a fit: Patients with known or suspected sexually transmitted diseases or those requiring immediate antibiotic treatment will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce unnecessary antibiotic prescriptions, thereby lowering antibiotic resistance rates and improving patient outcomes.
How similar studies have performed: Other studies have shown promise in using advanced diagnostic tools to reduce unnecessary antibiotic use, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients who are suspected to have LUTs in outpatient clinic. 2. Willing to consent to participate the trial. 3. Be able to understand the nature of the study. Exclusion Criteria: 1. Any suspected or known sexual transmitted diseases. (Such as gonorrhea, etc.) 2. Use of any systematic antibiotics or antiviral treatment within two weeks 3. With evidence of systematic infection including high fever, significantly increase of blood white blood cell count, etc. 4. Known or suspected allergic history/adverse drug reactions to any antibiotics 5. With previous history of multidrug resistant (MDR) bacterial infection. 6. Any medical history that indicates the need of immediate antibiotics treatment, such as chronic conditions and/or taking immunosuppressants.
Where this trial is running
Hong Kong, Hong Kong
- Queen Mary Hospital — Hong Kong, Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Research Assistant
- Email: stac@hku.hk
- Phone: 22554852
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.